Form 4: PEGA CPO Exercises Options, Sells Shares
Insider Transaction Report
Pegasystems CPO exercises options and sells shares.
Summary
- Rifat Kerim Akgonul, Chief Product Officer of Pegasystems Inc. (PEGA), reported transactions involving the company's common stock.
- On March 16, 2026, Mr. Akgonul exercised 30,000 stock options at an exercise price of $23.64 per share.
- Concurrently, 22,406 shares were disposed of at $43.36 per share to cover tax withholding obligations related to the option exercise.
- An additional 7,594 shares were sold on the open market at $43.39 per share.
- Following these transactions, Mr. Akgonul directly beneficially owns 111,429 shares of common stock.
- The stock options exercised were fully vested as of March 7, 2024, and had an expiration date of March 7, 2033.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While the exercise of options is positive, the immediate sale of shares, even partially for tax purposes, indicates profit-taking rather than an an increase in long-term holdings, balancing the sentiment.
Positives
- The exercise of 30,000 stock options at $23.64 indicates the officer realized value from their equity compensation.
Negatives
- A total of 30,000 shares were disposed of (22,406 for tax withholding and 7,594 through open market sale), reducing the officer's direct beneficial ownership from 141,429 shares to 111,429 shares.
Risks
- No specific risks related to company operations or financial health are disclosed in this Form 4 filing, which is a transaction report.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, detailing their transactions in company securities. The exercise of stock options and subsequent sale of shares, including for tax purposes, is a common practice for executives managing their equity compensation.
Comparison to Industry Standards
- This filing details standard executive equity compensation management. StockSavvy.ai does not identify specific comparable companies or projects within this filing to assess against global benchmarks, as it focuses solely on an individual's transaction.
Related Party Transactions
- The filing details transactions by a corporate officer, which are considered related-party transactions in the context of insider reporting.
Stakeholder Impact
- Shareholders: May observe the Chief Product Officer's decision to monetize a portion of their equity, which could be interpreted as a routine compensation event or a slight reduction in direct insider exposure.
Next Steps
- No specific future actions, events, or milestones are mentioned in this transaction report.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Stock option became fully vested. |
| 03/16/2026 | Date of stock option exercise, tax withholding, and open market sale transactions. |
| 03/17/2026 | Date the Form 4 was signed. |
| 03/07/2033 | Stock option expiration date. |
Recommendation
holdThis Form 4 details a routine executive transaction involving the exercise of stock options and subsequent sale of shares, including those for tax obligations. Such transactions are common and do not typically provide sufficient new information to warrant a change in investment recommendation for a seasoned investor. The officer still retains a significant number of shares.
Keywords
PEGASYSTEMS, PEGA, Form 4, insider transaction, stock options, executive compensation, Rifat Kerim Akgonul, Chief Product Officer, share sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.